BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38359305)

  • 1. Molecular Insights into the Inhibition and Disaggregation Effects of EGCG on Aβ40 and Aβ42 Cofibrillation.
    Li X; Zhang Y; Wang Y; Zhang S; Zhang L
    J Phys Chem B; 2024 Feb; 128(8):1843-1853. PubMed ID: 38359305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
    Dong M; Zhao W; Hu D; Ai H; Kang B
    ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting the Molecular Mechanisms of the Co-Aggregation of Aβ40 and Aβ42 Peptides: A REMD Simulation Study.
    Li X; Yang Z; Chen Y; Zhang S; Wei G; Zhang L
    J Phys Chem B; 2023 May; 127(18):4050-4060. PubMed ID: 37126408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green Tea Extracts EGCG and EGC Display Distinct Mechanisms in Disrupting Aβ
    Zhan C; Chen Y; Tang Y; Wei G
    ACS Chem Neurosci; 2020 Jun; 11(12):1841-1851. PubMed ID: 32441920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of resveratrol and EGCG in the inhibition of Aβ
    Li F; Zhan C; Dong X; Wei G
    Phys Chem Chem Phys; 2021 Sep; 23(34):18843-18854. PubMed ID: 34612422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of Nanoparticles with Green Tea for Inhibition of β-Amyloid Fibrillation Coupled with Ligands Analysis.
    Zhang M; Li Y; Han C; Chu S; Yu P; Cheng W
    Int J Nanomedicine; 2024; 19():4299-4317. PubMed ID: 38766654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamic analysis of the molecular interactions between amyloid beta-peptide 42 and (-)-epigallocatechin-3-gallate.
    Wang SH; Liu FF; Dong XY; Sun Y
    J Phys Chem B; 2010 Sep; 114(35):11576-83. PubMed ID: 20718413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils.
    Gu L; Guo Z
    J Neurochem; 2013 Aug; 126(3):305-11. PubMed ID: 23406382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
    Wang L; Eom K; Kwon T
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity.
    Jan A; Gokce O; Luthi-Carter R; Lashuel HA
    J Biol Chem; 2008 Oct; 283(42):28176-89. PubMed ID: 18694930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive contribution of two additional residues in protein aggregation of Aβ42 and Aβ40 isoforms.
    Im D; Choi TS
    BMB Rep; 2024 Jun; 57(6):263-272. PubMed ID: 38835114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green tea extract EGCG plays a dual role in Aβ
    Dong X; Tang Y; Zhan C; Wei G
    Chem Phys Lipids; 2021 Jan; 234():105024. PubMed ID: 33278382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aβ40 and Aβ42 amyloid fibrils exhibit distinct molecular recycling properties.
    Sánchez L; Madurga S; Pukala T; Vilaseca M; López-Iglesias C; Robinson CV; Giralt E; Carulla N
    J Am Chem Soc; 2011 May; 133(17):6505-8. PubMed ID: 21486030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions.
    Gu L; Guo Z
    Biochem Biophys Res Commun; 2021 Jan; 534():292-296. PubMed ID: 33272573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key Residue for Aggregation of Amyloid-β Peptides.
    Itoh SG; Yagi-Utsumi M; Kato K; Okumura H
    ACS Chem Neurosci; 2022 Nov; 13(22):3139-3151. PubMed ID: 36302506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
    Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
    Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodynamic analysis of the molecular interactions between amyloid β-protein fragments and (-)-epigallocatechin-3-gallate.
    Wang SH; Dong XY; Sun Y
    J Phys Chem B; 2012 May; 116(20):5803-9. PubMed ID: 22536844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into Molecular Mechanisms of EGCG and Apigenin on Disrupting Amyloid-Beta Protofibrils Based on Molecular Dynamics Simulations.
    Fang M; Zhang Q; Guan P; Su K; Wang X; Hu X
    J Phys Chem B; 2022 Oct; 126(41):8155-8165. PubMed ID: 36219848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of (-)-Epigallocatechin-3-Gallate on the Amyloid-β Secondary Structure.
    Acharya A; Stockmann J; Beyer L; Rudack T; Nabers A; Gumbart JC; Gerwert K; Batista VS
    Biophys J; 2020 Jul; 119(2):349-359. PubMed ID: 32579965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.